CBUS vs MOS
CBUS: Cibus is a gene-editing biotechnology company that licenses proprietary agricultural productivity traits and develops sustainable plant-based ingredients for the global seed and consumer markets. MOS: A global leader in crop nutrition, providing essential phosphate and potash fertilizers to support worldwide agricultural productivity.
Side-by-side fundamentals
| Metric | CBUS | MOS | Edge |
|---|---|---|---|
| Price as of 2026-08-11 close | $1.90 | $23.10 | |
| Market cap as of 2026-08-12 | $149M | $7.3B | |
| P/E as of 2026-08-12 | n/a | 13.34 | |
| PEG as of 2026-08-12 | n/a | 17.21 | |
| Net margin as of 2026-08-12 | -2366.3% | -5.2% | MOS higher |
| Gross margin as of 2026-08-12 | +100.0% | +11.0% | CBUS higher |
| Operating margin as of 2026-08-12 | -1588.4% | -1.4% | MOS higher |
| ROE as of 2026-08-12 | -225.6% | -5.3% | MOS higher |
| ROA as of 2026-08-12 | -31.1% | -2.6% | MOS higher |
| Debt / equity as of 2026-08-12 | 6.89 | 0.51 | MOS lower |
| Revenue growth (YoY) as of 2026-08-12 | -9.8% | +8.8% | MOS higher |
| Revenue CAGR (3y) SEC XBRL | +185.1% | -14.3% | CBUS higher |
| Dividend yield as of 2026-08-12 | n/a | +3.7% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-12 | 1.67 | 0.92 | |
| 1-year return as of 2026-08-11 close | +35.7% | -28.9% | CBUS higher |
Fundamentals: market data, as of 2026-08-12. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-11.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.